Synthesis of Aminoalkylated Aziridines from (+)-3-Carene

Curlat Serghei; Barba Alic; Boldescu Veaceslav; Pannecouque C.; Makaev Fliur

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

971

SM ISO690:2012

CURLAT, Serghei, BARBA, Alic, BOLDESCU, Veaceslav, PANNECOUQUE, C., MAKAEV, Fliur. Synthesis of Aminoalkylated Aziridines from (+)-3-Carene. In: Chemistry of Natural Compounds, 2019, nr. 2(55), pp. 269-274. ISSN 0009-3130. DOI: https://doi.org/10.1007/s10600-019-02664-0

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Chemistry of Natural Compounds

Numărul 2(55) / 2019 / ISSN 0009-3130

Synthesis of Aminoalkylated Aziridines from (+)-3-Carene

DOI:https://doi.org/10.1007/s10600-019-02664-0

Pag. 269-274

Curlat Serghei¹, Barba Alic¹, Boldescu Veaceslav¹, Pannecouque C.², Makaev Fliur¹

¹ Institute of Chemistry,
² Rega Institute for Medical Research

Disponibil în IBN: 6 iunie 2019

Rezumat

Aminoalkylated carane-type aziridines were synthesized via epoxidation of (+)-3-carene by H ₂ O ₂ solution (7%) in EtOAc catalyzed by α-Al ₂ O ₃ nanoparticles, opening of the epoxide by NaN ₃ , and cyclization of the azidoalcohol by Ph ₃ P followed by condensation of the resulting aziridines with formalin and secondary amines. The cytotoxicity of the aminoalkylated aziridines with heteroorganic substituents increased on going from a five-membered pyrrolidine ring substituent to a six-membered piperidine ring and decreased sharply upon replacing a piperidine by a morpholine ring or increased on going to a piperazine ring. The structures of products were established using IR and NMR spectroscopy and an X-ray crystal structure analysis. .

Cuvinte-cheie
( )-3-carene, aminoalkylation, aziridines, cytotoxicity

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-78918</cfResPublId>
<cfResPublDate>2019-03-15</cfResPublDate>
<cfVol>55</cfVol>
<cfIssue>2</cfIssue>
<cfStartPage>269</cfStartPage>
<cfISSN>0009-3130</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/78918</cfURI>
<cfTitle cfLangCode='EN' cfTrans='o'>Synthesis of Aminoalkylated Aziridines from (+)-3-Carene</cfTitle>
<cfKeyw cfLangCode='EN' cfTrans='o'>( )-3-carene; aminoalkylation; aziridines; cytotoxicity</cfKeyw>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>Aminoalkylated carane-type aziridines were synthesized via epoxidation of (+)-3-carene by H <sub>2</sub> O <sub>2</sub> solution (7%) in EtOAc catalyzed by &alpha;-Al <sub>2</sub> O <sub>3</sub> nanoparticles, opening of the epoxide by NaN <sub>3</sub> , and cyclization of the azidoalcohol by Ph <sub>3</sub> P followed by condensation of the resulting aziridines with formalin and secondary amines. The cytotoxicity of the aminoalkylated aziridines with heteroorganic substituents increased on going from a five-membered pyrrolidine ring substituent to a six-membered piperidine ring and decreased sharply upon replacing a piperidine by a morpholine ring or increased on going to a piperazine ring. The structures of products were established using IR and NMR spectroscopy and an X-ray crystal structure analysis. .</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2019-03-15T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2019-03-15T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-40916</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2019-03-15T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11134</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2019-03-15T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-14228</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2019-03-15T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-63717</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2019-03-15T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-4389</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2019-03-15T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfFedId>
<cfFedIdId>ibn-doi-78918</cfFedIdId>
<cfFedId>10.1007/s10600-019-02664-0</cfFedId>
<cfStartDate>2019-03-15T24:00:00</cfStartDate>
<cfFedId_Class>
<cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId>
<cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId>
</cfFedId_Class>
<cfFedId_Srv>
<cfSrvId>5123451</cfSrvId>
<cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId>
</cfFedId_Srv>
</cfFedId>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-40916</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-40916-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2019-03-15T24:00:00</cfStartDate>
<cfFamilyNames>Курлат</cfFamilyNames>
<cfFirstNames>Сергей</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11134</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11134-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2019-03-15T24:00:00</cfStartDate>
<cfFamilyNames>Barba</cfFamilyNames>
<cfFirstNames>Alic</cfFirstNames>
<cfFamilyNames>Барба</cfFamilyNames>
<cfFirstNames>Алик</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-14228</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-14228-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2019-03-15T24:00:00</cfStartDate>
<cfFamilyNames>Boldescu</cfFamilyNames>
<cfFirstNames>Veaceslav</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-63717</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-63717-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2019-03-15T24:00:00</cfStartDate>
<cfFamilyNames>Pannecouque</cfFamilyNames>
<cfFirstNames>C.</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-4389</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-4389-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2019-03-15T24:00:00</cfStartDate>
<cfFamilyNames>Makaev</cfFamilyNames>
<cfFirstNames>Fliur</cfFirstNames>
<cfFamilyNames>Макаев</cfFamilyNames>
<cfFirstNames>Флюр</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfSrv>
<cfSrvId>5123451</cfSrvId>
<cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName>
<cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr>
<cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw>
</cfSrv>
</CERIF>